California · Nonprofit
CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY
CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY (California) receives grants from 2 organizations whose IRS filings report $1,000 to it, the largest being AbbVie Foundation ($600). 0 of them have funded it in more than one year.
- Revenue FY2024
- $230k
- Funders on record
- 2
- Grants received
- $1k
- Net assets
- $288k
What Chinese-American Biopharmaceutical Society does
Mission
The Chinese American Biopharmaceutical Society (CABS) is a non-profit organization for professional in the biopharmaceutical industry. CABS is highly influential association with more than 3,000 members and subscribers in the life science industry. About 70% of our members have PhD degree relating to life sciences. A considerable proportion of the members are holding senior research and management positions in American and multi-national life science corporations. We organize many activities to promote international collaborations in life sciences and to provide Science & Technology Parks and life sciences companies in the Pacific Rim with an excellent platform to promote business and to recruit talent. CABS is helping members seeking collaboration opportunities in the Pacific Rim. To further meet the needs of CABS members, we are actively helping our members seeking partnership opportunities in the Pacific Rim:To co-sponsor scientific conference in biopharmaceutical fieldTo organize C
As stated on its FY2024 Form 990.
Programs
CABS Annual Conference:Program Revenue: $12,576 Program Expenses: $193,678
$193,678 spent$12,576 earned by the program88% of program spendingSpecial Social Events:Program Revenue: $10,592 Program Expenses: $24,384
$24,384 spent$10,592 earned by the program11% of program spendingWorkshop and Symposium:Program Revenue: $286 Program Expenses: $1,202
$1,202 spent$286 earned by the program1% of program spending
The 3 programs described on its FY2023 Form 990, listed largest first by expense. Program spending in total: $219,264.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2017 to 2018, from $170k to $253k (+49%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
90% of CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY’s revenue is contributions — more donation-reliant than the typical peer (79% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 8 reported years ran a deficit.
reserve
Who funds it, year by year
2020 → 2021: the base held at 1 funder, grant income fell $600 → $400.
From the IRS filings of CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY leans on a few funders — its largest provides 60% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
Largest funder’s share by year: 2020 100% · 2021 100% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY draws 60% of its grant income from funders outside California, across 2 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY is better cushioned than half of the 793 science & tech nonprofits its size.
this organization peer median middle 50% of peers· 793 science & tech nonprofits $100k–$1M, FY2024
Organizations like CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In California
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
90% of spending goes to programs.
Governance
Public support
100%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY?
- CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY (California) receives grants from 2 organizations whose IRS filings report $1,000 to it, the largest being AbbVie Foundation ($600). 0 of them have funded it in more than one year.
- How many funders does CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY have?
- IRS filings report 2 organizations giving $1,000 in grants to CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY.
- Who is the largest funder of CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY?
- AbbVie Foundation is the largest funder on record, with $600 in grants. The full list of funders is on this page.
- How can an organization like CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Chinese-American Biopharmaceutical Society →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 2 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing